Abstract: In one embodiment, a system for tracking and reversing accidental overdose includes a patient monitoring system configured to monitor a patient parameter that provides an indication as to whether or not the patient is overdosing, an alert system configured to activate when the patient parameter falls below an established threshold, and a reversal agent delivery system configured to automatically administer a reversing agent that counteracts the effects of an analgesic medication being administered to the patient when the patient parameter falls below the established threshold.

Abstract: The present invention relates to a combination of a pharmaceutical composition comprising a gallium compound, especially gallium nitrate, and one or more nonchemotherapeutic anticancer agents (NCAA) including antibodies, antisense molecules, anti-telomerase agents, aptamers, biologic response modifiers, bisphosphonates, cytotoxic fusion proteins, immunomodulatory agents, immunostimulatory agents, molecular decoys, molecular inhibitors, proteasome inhibitors, protein kinase inhibitors, retinoids, transcription factors and arsenic compounds, for the treatment of neoplasic disease in a mammal in need of treatment thereof.